Related Experiment Video
Updated: Aug 27, 2025
10:49
Printing Thermoresponsive Reverse Molds for the Creation of Patterned Two-component Hydrogels for 3D Cell Culture
Published on: July 10, 2013
15.2K
A scalable and tunable thermoreversible polymer for 3D human pluripotent stem cell biomanufacturing
Hunter J Johnson1,2, Saheli Chakraborty3, Riya J Muckom4
1Department of Bioengineering, University of California, Berkeley, Berkeley, CA 94720, USA.
Iscience
|September 23, 2022
Summary
Researchers developed a new 3D hydrogel platform for scalable human pluripotent stem cell (hPSC) production. This innovation addresses key challenges in cell therapy manufacturing, enabling high-quality cell expansion and differentiation.
Area of Science:
- Biotechnology
- Regenerative Medicine
- Materials Science
Background:
- Human pluripotent stem cells (hPSCs) hold promise for cell replacement therapies.
- Clinical translation is hindered by challenges in scalable, high-quality cell production, cellular immaturity, and animal-derived culture components.
Purpose of the Study:
- To develop a fully defined, reproducible, and tunable thermoreversible polymer hydrogel system.
- To enable scalable, high-quality 3D production of hPSCs and their derivatives.
Main Methods:
- Developed a novel thermoreversible polymer with precise control over gelation temperature and stiffness.
- Optimized material properties to prevent unintended covalent crosslinking.
- Demonstrated hPSC expansion, pluripotency maintenance, and differentiation within the 3D hydrogel environment.
Main Results:
- Achieved precise control of gelation temperature (24°C-32°C) and hydrogel stiffness (100-4000 Pa).
- Successfully maintained hPSC pluripotency and facilitated differentiation into multiple cell lineages within the hydrogel.
- Validated the platform for scalable, high-quality cell production.
Conclusions:
- The developed 3D thermoreversible hydrogel platform overcomes critical biomanufacturing limitations for stem cell therapies.
- This system offers a scalable and reproducible method for producing clinical-grade hPSCs.
- Broad applications are foreseen in advancing cell-based regenerative medicine.
